Computer-assisted papanicolaou imaging: Another valuable tool in the challenge of papanicolaou test screening for glandular neoplasia

Cancer Cytopathology

Volumn 118, Issue 2, 2010, Pages 65-67

  Austin, R Marshall ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; COMPUTER ASSISTED DIAGNOSIS; EARLY DIAGNOSIS; FEMALE; HUMAN; METHODOLOGY; NOTE; PATHOLOGY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERUS CANCER; VAGINA SMEAR;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; UTERINE NEOPLASMS; VAGINAL SMEARS;

EID: 77952558459     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20068     Document Type: Review

References (20)

1. Chute DJ, Lim H, Kong CS. BD FocalPoint Slide Profiler performance with atypical glandular cells on SurePath Papanicolaou smears. Cancer Cytopathol. 2010;118:68-74.
2. The International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer. 2006;120:885-891.
3. Mitchell H, Hocking J, Saville M. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening. Cancer Cytopathol. 2003; 99:336-341.
4. Mitchell H, Giles G, Medley G. Accuracy and survival benefit of cytological prediction of endometrial carcinoma on routine cervical smears. Int J Gynecol Pathol. 1993;12:34-40.
5. Smith HO, Benwick M, Qualls CF, Verschraegen CF, Wiggins C. 30 year trends in cervical cancer incidence rates: aSurveillance, Epidemiology, and End Results program population-based study. Abstract 196, presented at: Society of Gynecologic Oncologists' Annual Meeting; March 4-7, 2007; San Diego, California.
6. FocalPoint Slide Profiler product insert. Burlington, VT: Tri-Path Imaging. Available at: http://www.bd.com/tripath/downloads/msds-pi/focalpoint/ focalpoint-pi.pdf Accessed on March12, 2010.
7. Walts AE, Thomas P. Endometrial cells and the AutoPap system for primary screening of cervicovaginal pap smears. Diagn Cytopathol. 2002;27:232-237.
8. Wilbur DC, Parker EM, Foti JA. Location-guided screening of liquid-based cervical cytology specimens: a potential improvement in accuracy and productivity is demonstrated in a preclinical feasibility trial. Am J Clin Pathol. 2002;118: 399-407.
9. Rowe LR, Marshall CJ, Berry M, Larson MA, Bentz JS. Accuracy of a slide profiler for endocervical cell detection in no-further-review conventional Pap smears. Acta Cytol. 2003;47:602-604.
10. Wilbur DC, Black-Schaffer S, Luff RD, et al. The Becton Dickinson Focal Point GS Imaging System. Clinical trials demonstrate significantly improved sensitivity for the detection of important cervical lesions. Am J Pathol. 2009;132:767-775.
11. ThinPrep imaging system product insert. Marlborough, MA: Cytyc Corporation. Available at: http://www.thinprep.com/pdfs/thinprep-package-insert- imaging.pdf Accessed on March 12, 2010.
12. Davey E, d'Assuncao J, Irwig L, et al. Accuracy of reading liquid based cytology slides using the ThinPrep imager compared with conventional cytology: prospective study. BMJ. 2007;335:31.
13. Friedlander MA, Rudomina D, Lin O. Effectiveness of the Thin Prep imaging system in the detection of adenocarcinoma of the gynecologic system. Cancer. 2008;114:7-12.
14. Jayamohan Y, Karabakhtsian RG, Banks HW, Davey DD. Accuracy of Thinprep Imaging System in detecting atypical glandular cells. Diagn Cytopathol. 2009;37:479-482.
15. Begg CB, Greenes RA. Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics. 1983;39:207-215.
16. Cuzik J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006;119: 1095-1101.
17. Zhao C, Florea A, Onisko A, Austin RM. Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods. Gynecol Oncol. 2009;114:383-389.
18. Bansal M, Austin RM, Zhao C. High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and older. Gynecol Oncol. 2009;115:257-261.
19. Kitchener HC, Almonte M, Thomson C, et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol. 2009;10:672-682.
20. Kinney W, Sawaya G, Sung H, et al. Stage at diagnosis and mortality in patients with adenocarcinoma and adenosquamous carcinoma of the cervix diagnosed as a consequence of cytologic screening. Acta Cytol. 2003;47:167-171.